This compound is an antiviral pharmaceutical raw material supplied for manufacturing purposes. It consists of a tenofovir alafenamide-like prodrug moiety and fumaric acid forming a salt-like, multi-component structure.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 1432630-26-6
Tenofovir isoproxil monoester
Pharmaceutical intermediate for tenofovir prodrug
(((2-(6-amino-9H-purin-9-yl)ethoxy)methyl)phosphoryl)bis(oxy)bis(methylene) isopropyl dicarbonate
Pharmaceutical intermediate
((2R,5S)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolan-2-yl)methyl 2-hydroxybenzoate
antiviral active pharmaceutical ingredient
Maribavir
antiviral active pharmaceutical ingredient
Baloxavir
antiviral active pharmaceutical ingredient
파비피라비르
antiviral active pharmaceutical ingredient
Eletriptan
active pharmaceutical ingredient
NARATRIPTAN HYDROCHLORIDE
active pharmaceutical ingredient
[[(2S)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-(propan-2-yloxycarbonyloxymethoxy)phosphoryl]oxymethyl propan-2-yl carbonate;(E)-but-2-enedioic acid
VCMJCVGFSROFHV-KZHAMYRLSA-N
C[C@@H](CN1C=NC2=C(N=CN=C21)N)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C.C(=C/C(=O)O)\C(=O)O